Clinical Trials Directory

Trials / Unknown

UnknownNCT01169168

Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)

Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome, Sepsis, Chronicle Liver Disease or After Lysis on Intensive Care Units

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In this study patients with 1. chronicle liver diseases * primary biliary cirrhosis * primary sclerosing cholangitis * alcoholic liver cirrhosis * hepatitis b or C * Wilson's disease * cryptogenic cirrhosis 2. Septic Inflammatory Response Syndrome (SIRS) * sepsis * septic shock 3. patients after lysis should be included Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods. The methods are: * Clauss fibrinogen * PT-Derived fibrinogen * immunoturbidimetric method * heat-precipitated fibrinogen * Schulz fibrinogen The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.

Conditions

Timeline

Start date
2010-04-01
First posted
2010-07-26
Last updated
2010-07-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01169168. Inclusion in this directory is not an endorsement.

Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Dis (NCT01169168) · Clinical Trials Directory